Skip to main content
. 2013 Aug;20(8):981–989. doi: 10.1177/1933719112472740

Table 3.

Immunohistochemical Analysis of sFRP4 Expression in Patients With Severe PE and Normal Controls.

sFRP4 Immunostaining No Staining Weak Staining Moderate Staining Strong Staining
Control Group (n = 20) 4 12 4 0
Severe PE Group (n = 20) 1 5 12 2

Abbreviation: PE, preeclampsia.